ReEir Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$4.7M
- Investors
-
9
ReEir General Information
Description
Developer of a regenerative medicine platform designed to restore the bond between patients and society by treating serious illnesses with cell therapies derived from blood samples. The company offers innovative, simple, blood-based treatments, enabling patients with severe conditions to regain health.
Contact Information
Website
www.re-eir.com(Operating Subsidiary)
Corporate Office
- 12 Floor Garden Tower, 1-6-1 Roppongi
- Tokyo
- Minato-ku
- Japan
Corporate Office
- 12 Floor Garden Tower, 1-6-1 Roppongi
- Tokyo
- Minato-ku
- Japan
ReEir Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 17-Jul-2025 | $4.7M | Completed | Generating Revenue | ||
| 2. Merger/Acquisition | 09-Dec-2024 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 29-Sep-2017 | Completed | Startup |
ReEir Signals
ReEir FAQs
-
When was ReEir founded?
ReEir was founded in 2017.
-
Where is ReEir headquartered?
ReEir is headquartered in Minato-ku, Japan.
-
What is the size of ReEir?
ReEir has 6 total employees.
-
What industry is ReEir in?
ReEir’s primary industry is Drug Discovery.
-
Is ReEir a private or public company?
ReEir is a Private company.
-
What is ReEir’s current revenue?
The current revenue for ReEir is .
-
How much funding has ReEir raised over time?
ReEir has raised $4.7M.
-
When was ReEir acquired?
ReEir was acquired on 17-Jul-2025.
-
Who acquired ReEir?
ReEir was acquired by Hisamitsu Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process